Daniel A. Osman, MD

home / authors / daniel-a-osman-md

Articles

Dr. Osman on the 29th Miami Breast Cancer Conference

Dr. Osman on the 29th Miami Breast Cancer Conference

Daniel A. Osman, MD
March 15th 2012

Dr. Daniel Osman, the program chair for the Miami Breast Cancer Conference, Discusses the 29th Annual Meeting

Read More

Dr. Osman on Designing the Program for the MBCC

Dr. Osman on Designing the Program for the MBCC

Daniel A. Osman, MD
March 16th 2011

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Read More

Dr. Osman on Detecting Malignant Breast Cancer

Dr. Osman on Detecting Malignant Breast Cancer

Daniel A. Osman, MD
March 10th 2011

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer

Read More

Dr. Osman on Breast Cancer Changes in the Past 10 Years

Dr. Osman on Breast Cancer Changes in the Past 10 Years

Daniel A. Osman, MD
March 10th 2011

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data